European Journal of Pediatrics

, Volume 172, Issue 3, pp 351–356 | Cite as

Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt

  • Mohamed A. El-Khalawany
  • Hatem Hassan
  • Dalia Shaaban
  • Noha Ghonaim
  • Bayoumi Eassa
Original Article

Abstract

Topical therapy is usually of limited benefit in the treatment of severe atopic dermatitis (AD), and the need for a safe and effective systemic treatment may be required in certain cases especially in children. We evaluated the efficacy and safety of methotrexate and cyclosporine in the treatment of 40 children with severe AD. Patients were divided into two groups (each consisting of 20 patients); group A was treated with methotrexate (7.5 mg/week) while group B was treated with cyclosporine (2.5 mg/kg/day). The severity scoring for atopic dermatitis (SCORAD) was used to indicate efficacy of treatment. In group A, the mean SCORAD score at the beginning of the study was 57.90 ± 3.21 that was reduced at the end of the treatment period to reach 29.35 ± 6.32 with a mean absolute reduction of 26.25 ± 7.03. In group B, the mean SCORAD score was 56.54 ± 4.82 at the start of treatment and was 31.35 ± 8.89 at the end of 12 weeks of treatment. The mean absolute reduction was 25.02 ± 8.21. There was no statistically significant difference in the reduction of SCORAD score between both groups (P ± 0.93). Mild and temporary adverse effects were reported in some patients in both groups. Conclusion: Methotrexate or cyclosporine in low doses can be considered as effective, relatively safe, and well-tolerated treatments for severe AD in children.

Keywords

Atopic dermatitis Methotrexate Cyclosporine SCORAD 

References

  1. 1.
    Akdis CA, Akdis M, Biber T, Bindslev-Jensen C, Boquniewicz M, Eigenmann P, European Academy of Allergology, Clinical Immunology/American Academy of Allergy, Asthma And Immunology/PRACTALL Consensus Group (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152–169CrossRefPubMedGoogle Scholar
  2. 2.
    Balasubramaniam P, Ilchyshyn A (2005) Successful treatment of severe atopic dermatitis with methotrexate. Clin Exp Dermatol 30:436–440CrossRefPubMedGoogle Scholar
  3. 3.
    Bateman EA, Ardern-Jones M, Ogg GS (2007) Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate. Br J Dermatol 156:1376–1377CrossRefPubMedGoogle Scholar
  4. 4.
    Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, Salek MS, Allen BR, Smith S, Graham-Brown RA (1996) Cyclosporin in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 34:1016–1021CrossRefPubMedGoogle Scholar
  5. 5.
    Bunikowski R, Staab D, Kussebi F, Bräutigam M, Weidinger G, Renz H, Wahn U (2001) Low-dose cyclosporin a microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 12:216–223CrossRefPubMedGoogle Scholar
  6. 6.
    Caproni M, Salvatore E, Cardinali C, Brazzini B, Fabbri P (2000) Soluble CD30 and cyclosporin in severe atopic dermatitis. Int Arch Allergy Immunol 121:324–328CrossRefPubMedGoogle Scholar
  7. 7.
    Collin B, Vani A, Ogboli M, Moss C (2009) Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol 34:295–298CrossRefPubMedGoogle Scholar
  8. 8.
    Cordero Miranda MA, Casas Becerra B, Reyes Ruiz NI, Avila Castañón L, del Río Navarro BE, Sienra Monge JJ (2002) Cyclosporin A in atopic dermatitis. Rev Alerg Mex 49:129–134PubMedGoogle Scholar
  9. 9.
    Goujon C, Bérard F, Dahel K, Guillot I, Hennino A, Nosbaum A, Saad N, Nicolas JF (2006) Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol 16:155–158PubMedGoogle Scholar
  10. 10.
    Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, Finlay AY, Wilson NJ, Graham-Brown RA, Sowden JM, Beard AL, Sumner MJ, Berth-Jones J (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142:52–58CrossRefPubMedGoogle Scholar
  11. 11.
    Kaur I, Dogra S, De D, Kanwar AJ (2008) Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol 25:184–188CrossRefPubMedGoogle Scholar
  12. 12.
    Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology 195:10–19CrossRefPubMedGoogle Scholar
  13. 13.
    Lee SS, Tan AW, Giam YC (2004) Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study. Ann Acad Med Singapore 33:311–313PubMedGoogle Scholar
  14. 14.
    Leonardi S, Marchese G, Rotolo N, Miraglia Del Giudice M, La Rosa M (2004) Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases. Minerva Pediatr 56:231–237PubMedGoogle Scholar
  15. 15.
    Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151–160CrossRefPubMedGoogle Scholar
  16. 16.
    Nakata S, Uematsu K, Mori T, Mitsushita N, Kinoshita T, Ishioka C, Mutou K, Yokota S, Hirose Y, Komiyama A (1997) Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid. Nihon Rinsho Meneki Gakkai Kaishi 20:178–183CrossRefPubMedGoogle Scholar
  17. 17.
    Roberts H, Orchard D (2010) Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol 51:128–130CrossRefPubMedGoogle Scholar
  18. 18.
    Schmitt J, Schmitt N, Meurer M (2007) Cyclosporin in the treatment of patients with atopic eczema—a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 21:606–619PubMedGoogle Scholar
  19. 19.
    Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD (1991) Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137–140CrossRefPubMedGoogle Scholar
  20. 20.
    Su JC, Kemp AS, Varigos GA, Nolan TM (1997) Atopic eczema: its impact on the family and financial cost. Arch Dis Child 76:159–162CrossRefPubMedGoogle Scholar
  21. 21.
    Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ (2007) An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 156:346–351CrossRefPubMedGoogle Scholar
  22. 22.
    Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI (2006) Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 155:1013–1020CrossRefPubMedGoogle Scholar
  23. 23.
    Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 103:125–138CrossRefPubMedGoogle Scholar
  24. 24.
    Yip L, Darling S, Orchard D (2011) Lymphomatoid papulosis in children: experience of five cases and the treatment efficacy of methotrexate. Australas J Dermatol 52:279–283CrossRefPubMedGoogle Scholar
  25. 25.
    Zaki I, Emerson R, Allen BR (1996) Treatment of severe atopic dermatitis in childhood with cyclosporin. Br J Dermatol 135:21–24CrossRefPubMedGoogle Scholar
  26. 26.
    Zoller L, Ramon M, Bergman R (2008) Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Isr Med Assoc J 10:413–414PubMedGoogle Scholar
  27. 27.
    Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, Bos JD (1996) The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens. Br J Dermatol 135:15–20CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Mohamed A. El-Khalawany
    • 1
  • Hatem Hassan
    • 2
  • Dalia Shaaban
    • 3
  • Noha Ghonaim
    • 4
  • Bayoumi Eassa
    • 1
  1. 1.Department of Dermatology, Faculty of MedicineAl-Azhar University, Al-Hussein University HospitalCairoEgypt
  2. 2.Department of Dermatology, Faculty of MedicineAl-Azhar University, Dumyat University HospitalDamiettaEgypt
  3. 3.Department of Dermatology, Faculty of MedicineTanta UniversityTantaEgypt
  4. 4.Department of Dermatology, Faculty of MedicineAl-Azhar University, Al-Zahraa University HospitalCairoEgypt
  5. 5.Department of Dermatology, Faculty of MedicineAl-Azhar UniversityCairoEgypt

Personalised recommendations